Progress towards a new targeted treatment approach that will provide personalised medicine, rather than providing the same first line treatment for conditions, will amass more patient data than ever before. Being able to handle and store this data, whilst ensuring it is readily available for other healthcare organisations, is essential.
Additionally, with the cost of drug development rising and existing drugs coming off patent at an alarming rate, high-performing pharmaceutical firms are focusing on data-driven approaches to dramatically improve efficiencies across manufacturing, distribution and markets, while gaining better insight to drive improved decision making. It is estimated that such efficiencies could save the industry as much as $90bn.
With sales fast increasing and Pharmaceutical organisations looking at new forms of marketing and customer retention, it is clear that a new solution is required to ensure compliance, security and the ability to implement a data-driven approach. Cloud environments can underpin the deployment of the digital technologies you need to support transformation, for example combatting existing issues surrounding drug prescriptions by pharmaceutical organisations and patients' subsequent concerns around who has accessed their records. Similarly this could also enable pharmaceutical companies to develop a deeper insight and understanding of the NHS.
UKCloud Health offers a cost-effective cloud platform that represents genuine value-for-money, even when compared with global cloud platforms.